Evidence Level
Evening Primrose Oil (EPO) has been studied for its effects on various health conditions, with mixed results across applications. Research indicates that EPO may offer benefits in specific populations, though its clinical utility remains inconsistent.
For skin health, Muggli (2005) demonstrated that 500 mg/day of EPO over 12 weeks significantly improved skin moisture, TEWL, elasticity, and firmness in healthy adults. However, evidence for atopic dermatitis is more controversial. A Cochrane review by Bamford et al. (2013) concluded that oral EPO was not effective for eczema based on rigorous trials, though subgroup analyses suggested benefits in patients with low GLA levels, supporting the delta-6 desaturase deficiency hypothesis.
Beyond dermatology, recent studies have explored additional applications. Larki et al. (2025) conducted a systematic review/meta-analysis of six RCTs involving 450 women and found that EPO significantly reduced menopausal hot flash duration. Conversely, Ahmad Adni et al. (2021) reviewed 13 trials (1752 women) and concluded that EPO was ineffective for mastalgia compared to NSAIDs, danazol, or vitamin E.
In obstetrics, Moradi et al. (2021) systematically analyzed six trials and found no significant effect of EPO on cervical ripening or labor induction. However, Khorshidi et al. (2020) reported that EPO supplementation significantly reduced triglycerides and increased HDL in hyperlipidemic individuals based on a meta-analysis of six RCTs.
Overall, while the mechanistic rationale for EPO—restoring anti-inflammatory prostaglandin balance and supporting ceramide synthesis—remains sound, its clinical utility appears most consistent in specific populations, such as those with menopausal symptoms or skin conditions linked to GLA deficiency.